De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival. - Mittelbronn, M.; Capper, D.; Bunz, B.; Dietz, K.; Goeppert, B.; Ajaaj, R.; Tabatabai, G.; Stubenvoll, F.; Schlaszus, H.; Merseburger, A. S.; Becker, R.; Freudenstein, D.; et al. (Neuropathology & Applied Neurobiology, 2007)